Increasing resilience of medical supply chains during the COVID-19 pandemic
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
The pandemic-induced crisis will have severe impacts on household incomes and industries in the region and requires swift policy actions.
The recovery of supply chains can be supported through trade policies and firm-specific initiatives.
COVID-19 struck at the core of GVC hub regions, with severe implications for international production networks.